161 related articles for article (PubMed ID: 17722791)
21. [Non alcoholic fatty liver. A frequent entity with an unknown outcome].
Barisio D'Angelo MG; Mariel Actis A; Outomuro D
Rev Gastroenterol Peru; 2009; 29(1):44-50. PubMed ID: 19424408
[TBL] [Abstract][Full Text] [Related]
22. Evolving trends in nonalcoholic fatty liver disease.
Delgado JS
Eur J Intern Med; 2008 Mar; 19(2):75-82. PubMed ID: 18249301
[TBL] [Abstract][Full Text] [Related]
23. High-fat diet: a trigger of non-alcoholic steatohepatitis? Preliminary findings in obese subjects.
Vilar L; Oliveira CP; Faintuch J; Mello ES; Nogueira MA; Santos TE; Alves VA; Carrilho FJ
Nutrition; 2008; 24(11-12):1097-102. PubMed ID: 18640006
[TBL] [Abstract][Full Text] [Related]
24. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
Verna EC; Berk PD
Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
[TBL] [Abstract][Full Text] [Related]
25. Hepatic microcirculation in fatty liver disease.
Farrell GC; Teoh NC; McCuskey RS
Anat Rec (Hoboken); 2008 Jun; 291(6):684-92. PubMed ID: 18484615
[TBL] [Abstract][Full Text] [Related]
26. Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis.
Anderson N; Borlak J
Pharmacol Rev; 2008 Sep; 60(3):311-57. PubMed ID: 18922966
[TBL] [Abstract][Full Text] [Related]
27. Insulin resistance and steatosis in humans.
Capeau J
Diabetes Metab; 2008 Dec; 34(6 Pt 2):649-57. PubMed ID: 19195626
[TBL] [Abstract][Full Text] [Related]
28. [Diagnosis and therapy in NASH].
Tokushige K
Rinsho Byori; 2009 Sep; 57(9):848-53. PubMed ID: 19860210
[TBL] [Abstract][Full Text] [Related]
29. Endothelial dysfunction in Turkish patients with non-alcoholic fatty liver disease.
Senturk O; Kocaman O; Hulagu S; Sahin T; Aygun C; Konduk T; Celebi A
Intern Med J; 2008 Mar; 38(3):183-9. PubMed ID: 17725609
[TBL] [Abstract][Full Text] [Related]
30. Definition and natural history of metabolic steatosis: histology and cellular aspects.
Paradis V; Bedossa P
Diabetes Metab; 2008 Dec; 34(6 Pt 2):638-42. PubMed ID: 19195624
[TBL] [Abstract][Full Text] [Related]
31. Metabolic syndrome, non-alcoholic fatty liver disease and hepatitis C virus: impact on disease progression and treatment response.
Younossi ZM; McCullough AJ
Liver Int; 2009 Mar; 29 Suppl 2():3-12. PubMed ID: 19187068
[TBL] [Abstract][Full Text] [Related]
32. Non alcoholic steatohepatitis.
Zantout H; Barada K
J Med Liban; 2001; 49(2):90-3. PubMed ID: 11910973
[No Abstract] [Full Text] [Related]
33. Recent advances in nonalcholic fatty liver disease.
Greenfield V; Cheung O; Sanyal AJ
Curr Opin Gastroenterol; 2008 May; 24(3):320-7. PubMed ID: 18408460
[TBL] [Abstract][Full Text] [Related]
34. Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C.
Rafiq N; Younossi ZM
Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):207-15. PubMed ID: 19072356
[TBL] [Abstract][Full Text] [Related]
35. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice.
Cong WN; Tao RY; Tian JY; Liu GT; Ye F
Life Sci; 2008 May; 82(19-20):983-90. PubMed ID: 18417155
[TBL] [Abstract][Full Text] [Related]
36. Mitochondrial injury in steatohepatitis.
Pessayre D; Fromenty B; Mansouri A
Eur J Gastroenterol Hepatol; 2004 Nov; 16(11):1095-105. PubMed ID: 15489566
[TBL] [Abstract][Full Text] [Related]
37. Role of radiologic modalities in the management of non-alcoholic steatohepatitis.
Charatcharoenwitthaya P; Lindor KD
Clin Liver Dis; 2007 Feb; 11(1):37-54, viii. PubMed ID: 17544971
[TBL] [Abstract][Full Text] [Related]
38. Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis.
Marra F; Gastaldelli A; Svegliati Baroni G; Tell G; Tiribelli C
Trends Mol Med; 2008 Feb; 14(2):72-81. PubMed ID: 18218340
[TBL] [Abstract][Full Text] [Related]
39. Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels.
Wong VW; Wong GL; Tsang SW; Hui AY; Chan AW; Choi PC; Chim AM; Chu S; Chan FK; Sung JJ; Chan HL
Aliment Pharmacol Ther; 2009 Feb; 29(4):387-96. PubMed ID: 19035982
[TBL] [Abstract][Full Text] [Related]
40. [Nonalcoholic steatohepatitis: pathogenesis and treatment].
Park SH
Korean J Hepatol; 2008 Mar; 14(1):12-27. PubMed ID: 18367854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
